Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ General Mills, Worthington Enterprises And 3 Stocks To Watch Heading Into Wednesday (Benzinga) +++ WORTHINGTON ENTERPRISES Aktie +10,55%

IGC PHARMA Aktie

 >IGC PHARMA Aktienkurs 
0.266 EUR    (Tradegate)
Ask: 0.272 EUR / 7335 Stück
Bid: 0.26 EUR / 7711 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
IGC PHARMA Aktie über LYNX handeln
>IGC PHARMA Performance
1 Woche: -1,8%
1 Monat: -8,9%
3 Monate: -6,6%
6 Monate: -25,0%
1 Jahr: -41,7%
laufendes Jahr: -24,1%
>IGC PHARMA Aktie
Name:  IGC PHARMA INC. DL -,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US45408X3089 / A1T87A
Symbol/ Ticker:  IGS1 (Frankfurt)
Kürzel:  FRA:IGS1, ETR:IGS1, IGS1:GR
Index:  -
Webseite:  https://igcpharma.com/
Marktkapitalisierung:  20.61 Mio. EUR
Umsatz:  1.07 Mio. EUR
EBITDA:  -7.13 Mio. EUR
Gewinn je Aktie:  -0.086 EUR
Schulden:  0.23 Mio. EUR
Liquide Mittel:  0.41 Mio. EUR
Umsatz-/ Gewinnwachstum:  26% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  17.6 / 3.81 / -
Gewinnm./ Eigenkapitalr.:  - / -115.06%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Div. Historie:  14.09.20 - 0.5217€
Insiderhandel:  -
Suchwörter:  IGC PHARMA
Letzte Datenerhebung:  25.06.25
>IGC PHARMA Eigentümer
Aktien: 79.69 Mio. St.
f.h. Aktien: 71.19 Mio. St.
Insider Eigner: 7.52%
Instit. Eigner: 20.94%
Leerverk. Aktien: -
>IGC PHARMA Peer Group

 
23.06.25 - 14:42
 IGC Pharma, Inc.: IGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon (Accesswire)
 
POTOMAC, MD / ACCESS Newswire / June 23, 2025 / IGC Pharma, Inc. ("IGC", or the "Company") (NYSE American:IGC) today announced the addition of a new clinical trial site at Tekton Research in Yukon,......
22.05.25 - 15:42
 IGC Pharma, Inc.: IGC Pharma′s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer′s Market (Accesswire)
 
POTOMAC, MD / ACCESS Newswire / May 22, 2025 / IGC Pharma, Inc. ("IGC", or the "Company") (NYSE American:IGC) today announced a clinical trial site at Santa Cruz Behavioral in Puerto Rico for its C......
12.05.25 - 15:42
 IGC Pharma, Inc.: IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting (Accesswire)
 
POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity......
24.04.25 - 15:42
 IGC Pharma, Inc.: IGC Pharma Welcomes Strategic Investment from Advisors (Accesswire)
 
POTOMAC, MARYLAND / ACCESS Newswire / April 24, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that the Company's recently appointed advisors entered into a Sh......
21.04.25 - 15:42
 IGC Pharma, Inc.: IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer′s Innovation and AI-Driven Programs (Accesswire)
 
Industry Veterans Bring Deep Strategic Experience to Guide Alzheimer's Clinical Expansion and Commercial Strategy POTOMAC, MARYLAND / ACCESS Newswire / April 21, 2025 / IGC Pharma, Inc. (NYSE Ameri......
08.04.25 - 15:42
 IGC Pharma, Inc.: IGC Pharma Expands CALMA Alzheimer′s Phase 2 Trial with Prestigious Research Site at Butler Hospital′s Memory and Aging Program (Accesswire)
 
POTOMAC, MARYLAND / ACCESS Newswire / April 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") today announced the expansion of its ongoing Phase 2 CALMA clinical trial ......
01.04.25 - 15:18
 IGC Pharma, Inc.: IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health (Accesswire)
 
POTOMAC, MD / ACCESS Newswire / April 1, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the expansion of its Phase 2 clinical trial, CALMA, evaluating IGC-AD1 for the treatment of agit......
17.03.25 - 14:06
 IGC Pharma, Inc.: IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida (Accesswire)
 
POTOMAC, MARYLAND / ACCESS Newswire / March 17, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") today announced the addition of a new trial site at BayCare's St. Anthony......
12.03.25 - 14:06
 IGC Pharma, Inc.: IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25" (Accesswire)
 
POTOMAC, MARYLAND / ACCESS Newswire / March 12, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC) announces that Ascendiant Capital Markets has issued a coverage r......
10.03.25 - 14:06
 IGC Pharma, Inc.: IGC Pharma Announces Equity Analyst Update by Alliance Global Partners about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results" (Accesswire)
 
POTOMAC, MD / ACCESS Newswire / March 10, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC) announces that Alliance Global Partners (AGP) has issued an analyst upd......
18.02.25 - 18:36
 IGC Pharma GAAP EPS of -$0.02, revenue of $257M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.25 - 14:42
 IGC Pharma, Inc.: IGC Pharma Reports Third Quarter Fiscal 2025 Results (Accesswire)
 
POTOMAC, MARYLAND / ACCESS Newswire / February 18, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced its financial results for the third fiscal quarter of 2025 en......
15.02.25 - 01:00
 IGC Pharma, Inc. (IGC) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
 
IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of 33.33% and 28.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
11.02.25 - 14:42
 IGC Pharma, Inc.: IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby (Accesswire)
 
- Product Launch Leverages IGC's State-Of-The-Art Manufacturing Facility To Support Revenue-Generating Brand for Immunity & Energy - POTOMAC, MD / ACCESS Newswire / February 11, 2025 / IGC Pharma, ......
28.01.25 - 19:45
 IGC Pharma, Inc. (IGC) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
 
IGC Pharma, Inc. (IGC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy)....
28.01.25 - 14:42
 IGC Pharma, Inc.: IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer′s Disease (Accesswire)
 
POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the PREP......
21.01.25 - 14:42
 IGC Pharma, Inc.: IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor (Accesswire)
 
POTOMAC, MD / ACCESS Newswire / January 21, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is pleased to announce the appointment of Terry McAuliffe, the 72nd Governor ......
13.01.25 - 14:42
 IGC Pharma, Inc.: IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets (Accesswire)
 
POTOMAC, MD / ACCESSWIRE / January 13, 2025 / IGC Pharma, Inc (NYSE American:IGC) ("IGC" or the "Company"), today announced that CEO Ram Mukunda and CCO Claudia Grimaldi will be participating in a ......
08.01.25 - 14:42
 IGC Pharma, Inc.: IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer′s Agitation "CALMA" and Expands Recruitment Strategy (Accesswire)
 
Innovative use of geofencing technology boosts enrollment at select sites POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced......
20.12.24 - 01:06
 IGC Pharma, Inc.: IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025 (Accesswire)
 
POTOMAC, MD / ACCESSWIRE / December 19, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced that the Company's management team will participate in BIO Partnering @ ......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer das Recht mit Füßen tritt, steht selten fest auf den Beinen. - Stanislaw Jerzy Lec
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!